HF
AMPE

HRT Financial’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

HRT Financial’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,962
Closed -$36K – 3376
2023
Q4 		$36K Buy
+17,962
New +$46.5K ﹤0.01% 1988
2023
Q3 		– Sell
-5,202
Closed -$24K – 3438
2023
Q2 		$24K Sell
5,202
-5,651
-52% -$27.7K ﹤0.01% 2082
2023
Q1 		$50K Buy
10,853
+10,129
+1,399% +$56.9K ﹤0.01% 2126
2022
Q4 		$3K Buy
724
+644
+805% +$4.15K ﹤0.01% 2323
2022
Q3 		$1K Sell
80
-586
-88% -$20.5K ﹤0.01% 2695
2022
Q2 		$33K Buy
+666
New +$49.6K ﹤0.01% 2557
2021
Q2 		– Sell
-1,657
Closed -$839K – 3768
2021
Q1 		$839K Buy
+1,657
New +$855K 0.01% 1311

Other funds holding AMPE

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HRT Financial's AMPE Position: Q1 2024 in Review

HRT Financial sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2024, closing a stake of 17,962 shares — an estimated $36K sold.

HRT Financial first reported a position in AMPE in Q1 2021 and held it in 7 quarters. The position peaked at $839K in Q1 2021. 28 funds tracked by Wall St. Rank hold AMPE as of Q1 2024.

  • HRT Financial reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 17,962 Ampio Pharmaceuticals Inc. shares in Q1 2024, an estimated $36K.
  • HRT Financial first reported a position in Ampio Pharmaceuticals Inc. in Q1 2021 and held it in 7 quarters.
  • HRT Financial's Ampio Pharmaceuticals Inc. position peaked at $839K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.